XTX Topco »

Actuate Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2026-03-31 $41k 15k 2.74

More positions owned by XTX Topco

Ishares Msci Sth Kor Etf (EWY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
State Str Spdr Dow Jones Ind Ut Ser 1 (DIA)
Cme (CME)
NVIDIA Corporation (NVDA)
Citigroup Com New (C)
Duke Energy Corp Com New (DUK)
Goldman Sachs (GS)
Ge Aerospace Com New (GE)
Boston Scientific Corporation (BSX)
Parker-Hannifin Corporation (PH)
Amazon (AMZN)
American Electric Power Company (AEP)
Visa Com Cl A (V)
Dow (DOW)

View all positions for XTX Topco

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Palogic Value Management
Northern Trust
Texas Capital Bank Wealth Management Services
State Street Corporation
Vanguard Fiduciary Trust
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics